🇺🇸 Amoxicillin clavulanic in United States
7,066 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 22 April 2025 – 22 April 2026
- Total reports: 7,066
Most-reported reactions
- Drug Ineffective — 1,228 reports (17.38%)
- Pyrexia — 817 reports (11.56%)
- Off Label Use — 796 reports (11.27%)
- Diarrhoea — 725 reports (10.26%)
- Dyspnoea — 709 reports (10.03%)
- Drug-Induced Liver Injury — 678 reports (9.6%)
- Pruritus — 542 reports (7.67%)
- Vomiting — 534 reports (7.56%)
- Condition Aggravated — 525 reports (7.43%)
- Acute Kidney Injury — 512 reports (7.25%)
Other Infectious Disease approved in United States
Frequently asked questions
Is Amoxicillin clavulanic approved in United States?
Amoxicillin clavulanic does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Amoxicillin clavulanic in United States?
Hospital Italiano de Buenos Aires is the originator. The local marketing authorisation holder may differ — check the official source linked above.